Invokana 300mg Tablet 30s (Box)

Invokana 300mg Tablet 30s (Box) belongs to the drug class called sodium-glucose co-transporter 2 (SGLT2) inhibitors. Common side effects of Invokana 300mg Tablet 30s (Box) may include urinary tract infections, increased urination, and genital yeast infections. Patients taking this medication should be aware of the importance of staying hydrated and monitoring their blood sugar levels regularly. (Product_name) belongs to the class of medications known as SGLT2 inhibitors, and it has an active ingredient called canagliflozin.

Invokana 300mg Tablet 30s (Box) should be taken once daily by mouth, preferably before the first meal of the day. It can be taken with or without food. It is important to follow the dosage instructions provided by the healthcare professional.

The recommended dosage range for Invokana 300mg Tablet 30s (Box) is 100-300mg once daily. The actual dose prescribed will depend on various factors, including the patient's individual response and tolerability. It is important to take the medication as directed by the healthcare professional.

The shelf life of Invokana 300mg Tablet 30s (Box) is typically three years from the date of manufacture. It is important to check the expiration date on the packaging and consult a pharmacist if unsure about the product's suitability for use.

Invokana 300mg Tablet 30s (Box) should be stored at room temperature, away from excessive heat and moisture. It is important to keep the medication in its original container, tightly closed, and out of reach of children.

• Urinary tract infections
• Increased urination
• Genital yeast infections
• Hypotension (low blood pressure)
• Increased cholesterol levels
  

Invokana 300mg Tablet 30s (Box) is contraindicated in patients with severe renal impairment, end-stage renal disease, or who are on dialysis. It should not be used in patients with a history of hypersensitivity or serious allergic reactions to canagliflozin or any of its components.

Invokana 300mg Tablet 30s (Box) may interact with certain medications and substances, including diuretics, insulin, sulfonylureas, and drugs that may increase the risk of hypoglycemia. It is important to inform the healthcare professional about all the medications, supplements, and herbal products being taken before starting Invokana 300mg Tablet 30s (Box).

Take Invokana 300mg Tablet 30s (Box) as prescribed by the healthcare professional.

Monitor blood sugar levels regularly and report any significant changes or concerns to the healthcare professional.

Stay hydrated and drink plenty of fluids while taking Invokana 300mg Tablet 30s (Box).

Follow a healthy diet and exercise regimen as recommended by the healthcare professional.

Inform the healthcare professional about any other medical conditions or medications being taken.

1. Can Invokana 300mg Tablet 30s (Box) be used as a first-line treatment for type 2 diabetes?
   No, Invokana 300mg Tablet 30s (Box) cannot be used for type 2 diabetes.

2. Can Invokana 300mg Tablet 30s (Box) cause weight loss?
   Yes, some patients may experience weight loss while taking Invokana 300mg Tablet 30s (Box). However, weight loss can vary among individuals and should not be the primary reason for taking the medication.

3. What class of medication does Invokana 300mg Tablet 30s (Box) belong to, and what is its active ingredient?
   (Product_name) belongs to the class of medications known as SGLT2 inhibitors, and its active ingredient is canagliflozin.